Workflow
Prnewswire
icon
Search documents
eHealth Named to 2025 Fortune Best Workplaces in Texas by Fortune Media and Great Place To Work
Prnewswire· 2025-06-12 13:00
AUSTIN, Texas, June 12, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (eHealth.com), a leading online private health insurance marketplace, has been named as one of this year's Best Workplaces in Texas by Great Place To Work and Fortune magazine. eHealth is proud to be named to this prestigious list, coming in at No. 25. To be selected, eHealth surpassed rigorous benchmarks and has established itself as one of the best workplaces in Texas. The Best Workplaces in Texas list is highly competitive. Survey ...
Pomerantz Law Firm Announces the Filing of a Class Action Against Red Cat Holdings, Inc. and Certain Officers - RCAT
Prnewswire· 2025-06-12 13:00
NEW YORK, June 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Red Cat Holdings, Inc. ("Red Cat" or the "Company") (NASDAQ: RCAT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25- cv-05427, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Red Cat securities between March 18, 2022 and January 15, 202 ...
Medtronic announces MiniMed as name for planned New Diabetes Company
Prnewswire· 2025-06-12 13:00
Medtronic is targeting completion of the planned separation within 18 months of the initial announcement, subject to customary conditions and legal requirements including consultations with works councils and other employee representative bodies. GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, refl ...
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
Prnewswire· 2025-06-12 13:00
[Click here for information about joining the class action] NEW YORK, June 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv- 03221, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired PepGen ...
Walter Pat's Bakery Cafe Wins $100,000 2025 Comerica Hatch Detroit Contest by TechTown
Prnewswire· 2025-06-12 12:55
Funds and technical support will help 2025 winner bring seasonal bakery to DetroitDETROIT, June 12, 2025 /PRNewswire/ -- The winning small business of the 2025 Comerica Hatch Detroit Contest by TechTown has been announced! Walter Pat's Bakery Cafe is the winner of the 13th annual Comerica Hatch Detroit Contest, taking home the $100,000 grand prize from Comerica Bank to open the brick-and-mortar business of their dreams in Detroit, Hamtramck or Highland Park, as well as a business support package from TechTo ...
Enable Complete Cyber Resilience with Commvault at AWS re:Inforce
Prnewswire· 2025-06-12 12:50
Visit booth #631 for product demos, expert insight, networking opportunities, and more TINTON FALLS, N.J., June 12, 2025 /PRNewswire/ -- Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, is excited to announce its showcase at AWS re:Inforce, running June 16-18 in Philadelphia.Every year, AWS re:Inforce draws thousands of security professionals interested in learning how to enhance their organization's cloud security posture. Attendees range from CISOs and ...
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
Prnewswire· 2025-06-12 12:35
Core Viewpoint - Citius Pharmaceuticals Inc. has successfully closed a registered direct offering, raising approximately $6 million, with potential additional proceeds of up to $9.8 million from short-term warrants [1][3]. Group 1: Offering Details - The offering consisted of 4,920,000 shares of common stock priced at $1.22 per share, along with short-term warrants to purchase an additional 9,840,000 shares [1][3]. - The short-term warrants have an exercise price of $1.00 per share, are immediately exercisable, and will expire 24 months from the initial exercise date [1][3]. Group 2: Use of Proceeds - The net proceeds from the offering are intended to support the commercial launch of LYMPHIR™, including milestone and regulatory payments, as well as general corporate purposes [3]. Group 3: Company Background - Citius Pharmaceuticals is focused on developing first-in-class critical care products, with LYMPHIR approved by the FDA for treating cutaneous T-cell lymphoma [6]. - The company also has a late-stage pipeline that includes Mino-Lok®, an antibiotic lock solution, and CITI-002 (Halo-Lido), a topical formulation for hemorrhoid relief [6].
ASIAN MANUFACTURING ACTIVITY FALLS TO 17-MONTH LOW AS TARIFFS HIT CHINA-BASED SUPPLIERS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
Prnewswire· 2025-06-12 12:05
U.S. manufacturers front-load inventories in anticipation of further tariffs North American factories remain underutilized, with persistent weakness in Mexico and Canada Europe inches toward industrial recovery, while U.K. downturn deepens CLARK, N.J., June 12, 2025 /PRNewswire/ -- GEP Global Supply Chain Volatility Index — a leading indicator tracking demand conditions, shortages, transportation costs, inventories, and backlogs based on a monthly survey of 27,000 businesses — fell to -0.46 in May, from ...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Prnewswire· 2025-06-12 12:03
WILMINGTON, Del., June 12, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), a multi-site clinical care delivery organization and wholly-owned subsidiary of NRx, today announced participation in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, scheduled for June 16–17, 2025. HOPE Therapeutics, Inc. (PRNewsfoto/NRx Pharmaceut ...
Seekr Selects Oracle Cloud Infrastructure to Deliver Trusted AI to Enterprise and Government Customers Globally
Prnewswire· 2025-06-12 12:00
Seekr chooses OCI AI Infrastructure and AMD GPUs to rapidly deploy secure, transparent enterprise AI, and develop next-gen vision-language foundation modelsAUSTIN, Texas, June 12, 2025 /PRNewswire/ -- Seekr, an artificial intelligence company focused on delivering trusted AI, has entered a multi-year agreement with Oracle Cloud Infrastructure (OCI) to rapidly accelerate enterprise AI deployments, and execute a joint go-to-market strategy. In addition, Seekr is leveraging OCI to expand its multi-node trainin ...